Trial Profile
Arrest Imatinib or Dasatinib in CML patients with Deep Molecular Responses (AID MORE)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Feb 2018
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary) ; Imatinib
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms AID MORE
- 07 Feb 2018 New trial record